Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pulmonology
•
Pulmonary Vascular Disease
What patient related factors and hemodynamic parameters would lead you to avoid transbronchial biopsies in patients with pulmonary hypertension?
Answer from: at Community Practice
I try to avoid if INR is > 1.7 or platelet count is less than 30,000 in patients who have Grp I PAH.
Sign in or Register to read more
14421
Related Questions
How long post operatively do you wait before transitioning from parenteral anticoagulation to oral anticoagulants after pulmonary thromboendarterectomy for CTEPH?
Do you measure pleural pressure during right heart catheterization to obtain a wedge pressure in obese patients?
How would you approach a pulmonary-renal PR3+ ANCA vasculitis patient who has persistent re-narrowing of mainstem bronchus after several dilatation and stenting procedures, with other anca features well-controlled on rituximab & avacopan?
Do you obtain an echocardiogram as a part of risk stratification in all patients hospitalized with an acute pulmonary embolism?
What’s your approach to treatment of low to intermediate-low risk category precapillary PH in ESRD patients?
How does your approach to subsegmental PE differ from segmental PE both diagnostically and therapeutically?
How do you follow pulmonary embolism patients who have completed anticoagulation?
Do you consider pulmonary hypertension related to sarcoidosis to be an indication to start steroids?
How do you manage concurrent nonlife-threatening hemoptysis and acute pulmonary embolism?
When do you consider the use of PH specific therapies in patients with pre-capillary pulmonary hypertension associated with sickle cell disease?